Biotech Stocks Facing FDA Decision In December

With already 51 new molecular entities, or NMEs, getting greenlighted by the FDA so far this year, and still 1 more month to go, 2018 could be a banner year. This outpaces the 53 new drugs approved in 1996 - the highest ever.

from RTT - Biotech https://ift.tt/2FGBGRY
via IFTTT